Sign In
Media & Investors
Skip Navigation LinksSanten > Europe > Media & Investors > News > Santen participates at the upcoming Congress of the European Society of Ophthalmology from June 6-9
Contact
Santen Pharmaceutical welcomes your inquiries and opinions.

Santen participates at the upcoming Congress of the European Society of Ophthalmology from June 6-9

5/21/2015

Paris (France) – May 21, 2015 – Santen announces it will be participating at the upcoming Congress of the European Society of Ophthalmology (SOE) that takes place in Vienna, Austria from June 6 to 9, 2015. About 5.000 delegates from 150 countries will be expected and are invited to visit us at booth number 57.

 

At the congress "a selection of the best lecturers in the world will share every conceivable aspect of ophthalmology and the most recent state-of-art equipment and devices will be on display at the exhibition," said Stefan Seregard, President of SOE1.

 

This year, diamond sponsor Santen also organizes three satellite symposia covering advances on dry eye, glaucoma and uveitis management:

 

"Changing paradigms of treating severe keratitis in dry eye disease"
June 7, 12-1 pm, Hall A Plenary
Chairman: Christophe Baudouin, France
Speakers: Andrea Leonardi, Italy - Gysbert van Setten, Sweden -  Mourad Amrane, France

"Back to the future: Has medical treatment of glaucoma improved?"
June 8, 12-1 pm, Hall B
Chairman: Carlo E. Traverso, Italy
Speakers: Norbert Pfeiffer, Germany -  Gábor  Holló, Hungary -  Lutz Pillunat, Germany

 

"The art of immunoregulation in non-infectious uveitis"
June 8, 2.30-4 pm, Room 1.61/62, Level 1
Chairman: Yosuf El-Shabrawi, Austria
Speakers: Elisabetta Miserocchi, Italy - Sunil Srivastava, USA

About Santen

As a specialty company dedicated to the ophthalmic and anti-rheumatic fields, Santen carries out the research, development, sales, and marketing of pharmaceuticals. The company has its bases in about 20 countries and delivers products in more than 70 countries. In Japan, Santen holds the No. 1 share in the prescription ophthalmic pharmaceutical market. As a leading company in the field of ophthalmology, Santen aims to contribute to society by supplying valuable products and services to satisfy unmet medical needs.

Santen Forward-looking Statements

This press release is also prepared in other languages. However this English document is the original document, and documents prepared in other languages are for your reference only. In case of any discrepancy between the English and translated versions, the English version will prevail. Please refer to http://www.santen.eu for the original English document.

Contacts

Media Relations

Nicolas Merigeau

Emmanuel Huynh

NewCap. 

nmerigeau@newcap.fr

Tel: +33-1-4471-9498

Santen

Geneviève Garrigos

Corporate Communication Director - Santen Europe

Tel: +33-6-6554-6019

 

1Reference: http://soe2015.org/